Literature DB >> 25446730

IBD: cathelicidin can reverse intestinal fibrosis in models of colitis.

Isobel Leake.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25446730     DOI： 10.1038/nrgastro.2014.214

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Anti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosis.

Authors:  Jun Hwan Yoo; Samantha Ho; Deanna Hoang-Yen Tran; Michelle Cheng; Kyriaki Bakirtzi; Yuzu Kukota; Ryan Ichikawa; Bowei Su; Diana Hoang-Ngoc Tran; Tressia C Hing; Irene Chang; David Q Shih; Richard E Issacson; Richard L Gallo; Claudio Fiocchi; Charalabos Pothoulakis; Hon Wai Koon
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-01
  1 in total
  3 in total

1.  Targeting Gremlin 1 Prevents Intestinal Fibrosis Progression by Inhibiting the Fatty Acid Oxidation of Fibroblast Cells.

Authors:  Yang Yang; Qi-Shan Zeng; Min Zou; Jian Zeng; Jiao Nie; DongFeng Chen; Hua-Tian Gan
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 2.  Antimicrobial peptides in 2014.

Authors:  Guangshun Wang; Biswajit Mishra; Kyle Lau; Tamara Lushnikova; Radha Golla; Xiuqing Wang
Journal:  Pharmaceuticals (Basel)       Date:  2015-03-23

Review 3.  Bioinspired Designs, Molecular Premise and Tools for Evaluating the Ecological Importance of Antimicrobial Peptides.

Authors:  Elvis Legala Ongey; Stephan Pflugmacher; Peter Neubauer
Journal:  Pharmaceuticals (Basel)       Date:  2018-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.